Added to YB: 2019-06-11
Pitch date: 2019-06-11
IOVA:US [bullish]
Iovance Biotherapeutics, Inc.
-84.95%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.
Market Cap
$1.0B
Pitch Price
$18.94
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.17
P/E
-2.14
EV/Sales
3.08
Sector
Biotechnology
Category
N/A
Show full summary:
Iovance Biotherapeutics Inc IOVA:US
A summary for this pitch has not been created yet.
Read full article (0 min)